Ke Zuo

1.0k total citations
36 papers, 725 citations indexed

About

Ke Zuo is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ke Zuo has authored 36 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 11 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ke Zuo's work include Renal Diseases and Glomerulopathies (12 papers), Chronic Kidney Disease and Diabetes (7 papers) and Renal and Vascular Pathologies (5 papers). Ke Zuo is often cited by papers focused on Renal Diseases and Glomerulopathies (12 papers), Chronic Kidney Disease and Diabetes (7 papers) and Renal and Vascular Pathologies (5 papers). Ke Zuo collaborates with scholars based in China and United States. Ke Zuo's co-authors include Zhihong Liu, Caihong Zeng, Shijun Li, Laurence H. Beck, Weisong Qin, Zhaohong Chen, David J. Salant, Jiong Zhang, Feng Xu and Weibo Le and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Ke Zuo

31 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Zuo China 12 473 231 221 204 69 36 725
Nicole K. Andeen United States 13 349 0.7× 78 0.3× 124 0.6× 264 1.3× 66 1.0× 73 602
Simona Vatrano Italy 14 76 0.2× 66 0.3× 317 1.4× 136 0.7× 55 0.8× 44 702
Aurora Poon Australia 16 156 0.3× 25 0.1× 269 1.2× 126 0.6× 27 0.4× 32 800
Malte Kircher Germany 18 45 0.1× 123 0.5× 209 0.9× 218 1.1× 118 1.7× 60 1.0k
Matthew A. Nehs United States 23 102 0.2× 161 0.7× 133 0.6× 400 2.0× 150 2.2× 54 1.5k
Ming Y. Tung United States 8 64 0.1× 28 0.1× 209 0.9× 245 1.2× 73 1.1× 9 578
Philip M. Spanheimer United States 18 41 0.1× 101 0.4× 159 0.7× 307 1.5× 38 0.6× 63 865
Cecilia Wassberg Sweden 14 86 0.2× 21 0.1× 332 1.5× 241 1.2× 20 0.3× 33 982
Lea Baer United States 7 38 0.1× 57 0.2× 190 0.9× 92 0.5× 25 0.4× 18 632
Nicola Calvani Italy 16 39 0.1× 33 0.1× 139 0.6× 325 1.6× 296 4.3× 46 911

Countries citing papers authored by Ke Zuo

Since Specialization
Citations

This map shows the geographic impact of Ke Zuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Zuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Zuo more than expected).

Fields of papers citing papers by Ke Zuo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Zuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Zuo. The network helps show where Ke Zuo may publish in the future.

Co-authorship network of co-authors of Ke Zuo

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Zuo. A scholar is included among the top collaborators of Ke Zuo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Zuo. Ke Zuo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Li, Yuyun Sun, Ke Zuo, et al.. (2025). Pilot Study of Nectin-4–Targeted PET Imaging Agent68Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human. Journal of Nuclear Medicine. 66(3). 473–479. 5 indexed citations
2.
CHEN, DUQUN, et al.. (2024). Obinutuzumab Is Effective and Safe for Membranous Nephropathy with Very High Risk: A Retrospective Study from China. Journal of the American Society of Nephrology. 35(10S).
3.
Feng, Zheng, Ke Zuo, Xingzhu Ju, et al.. (2023). Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer. Journal of Ovarian Research. 16(1). 1 indexed citations
4.
Zhang, Yang, Yao Fu, Xiaozhi Zhao, et al.. (2022). Single-cell chromatin accessibility landscape in kidney identifies additional cell-of-origin in heterogenous papillary renal cell carcinoma. Nature Communications. 13(1). 31–31. 31 indexed citations
5.
Zuo, Ke, Jin Zhang, & Lintao Zeng. (2022). A smartphone-adaptable chromogenic and fluorogenic sensor for rapid visual detection of toxic hydrazine in the environment. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 283. 121765–121765. 15 indexed citations
6.
7.
CHEN, DUQUN, et al.. (2021). Long-term renal outcomes of mesangial proliferative lupus nephritis in Chinese patients. Clinical Rheumatology. 41(2). 429–436. 7 indexed citations
8.
Huang, Yunxia, Yaling Chen, Shiping Li, et al.. (2021). Development and Validation of a Simple-to-Use Nomogram for Predicting the Upgrade of Atypical Ductal Hyperplasia on Core Needle Biopsy in Ultrasound-Detected Breast Lesions. Frontiers in Oncology. 10. 609841–609841. 10 indexed citations
9.
10.
Zhang, Ti, Wei Zhang, Ke Zuo, & Zhen Cheng. (2020). Clinicopathologic Features and Outcomes in Fibronectin Glomerulopathy: A Case Series of 19 Patients. Frontiers in Medicine. 7. 439–439. 6 indexed citations
11.
Zhang, Ti, Fan Yang, Ke Zuo, et al.. (2020). HLA-B27 Negativity Is Associated With Renal Function Decline in Patients With Ankylosing Spondylitis and Secondary IgA Nephropathy. Frontiers in Medicine. 7. 89–89. 5 indexed citations
12.
Zuo, Ke, et al.. (2019). Structural basis of sequence-specific Holliday junction cleavage by MOC1. Nature Chemical Biology. 15(12). 1241–1248. 18 indexed citations
13.
Sun, Xiangjie, Ke Zuo, Dan Huang, et al.. (2017). Pancreatic metastasis from invasive pleomorphic lobular carcinoma of the breast: a rare case report. Diagnostic Pathology. 12(1). 52–52. 6 indexed citations
14.
Wang, Yu, Pengfei Zheng, Xia Wang, Ke Zuo, & Zhihong Liu. (2017). Proteomic profile-based screening of potential protein biomarkers in the urine of patients with nephrotic syndrome. Molecular Medicine Reports. 16(5). 6276–6284. 15 indexed citations
15.
Sun, Xin, Ke Zuo, Shenli Tang, et al.. (2017). [Correlation between androgen receptor expression and surrogate molecular subtypes in invasive breast carcinoma].. PubMed. 46(7). 476–480. 1 indexed citations
16.
Liang, Li, et al.. (2016). [Molecular recognition mechanism and motion of HCV NS3/4A protease with Faldaprevir analogue].. Chinese journal of biotechnology/Shengwu gongcheng xuebao. 32(5). 669–682. 1 indexed citations
17.
Zhang, Mingchao, Weibo Le, Caihong Zeng, et al.. (2016). Combined Assessment of Phospholipase A2 Receptor Autoantibodies and Glomerular Deposits in Membranous Nephropathy. Journal of the American Society of Nephrology. 27(10). 3195–3203. 67 indexed citations
18.
Zuo, Ke, Dong Kuang, Ying Wang, et al.. (2016). SCF/c-kit transactivates CXCR4-serine 339 phosphorylation through G protein-coupled receptor kinase 6 and regulates cardiac stem cell migration. Scientific Reports. 6(1). 26812–26812. 19 indexed citations
19.
Zuo, Ke, Yan Wu, Shijun Li, et al.. (2013). Long-term outcome and prognostic factors of idiopathic membranous nephropathy in the Chinese population. Clinical Nephrology. 79(6). 445–453. 35 indexed citations
20.
Qin, Weisong, Laurence H. Beck, Caihong Zeng, et al.. (2011). Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy. Journal of the American Society of Nephrology. 22(6). 1137–1143. 319 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole K. Andeen Breakdown of academic impact, for papers by Simona Vatrano Breakdown of academic impact, for papers by Aurora Poon Breakdown of academic impact, for papers by Malte Kircher Breakdown of academic impact, for papers by Matthew A. Nehs Breakdown of academic impact, for papers by Ming Y. Tung Breakdown of academic impact, for papers by Philip M. Spanheimer Breakdown of academic impact, for papers by Cecilia Wassberg Breakdown of academic impact, for papers by Lea Baer Breakdown of academic impact, for papers by Nicola Calvani
Rankless by CCL
2026